<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>02594cab a2200337Ia 45 0</leader>
  <controlfield tag="001">u210887</controlfield>
  <controlfield tag="003">SIRSI</controlfield>
  <controlfield tag="008">110402s2014    ua     ss b         eng d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">EAL</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
    <subfield code="b">ara</subfield>
  </datafield>
  <datafield tag="090" ind1=" " ind2=" ">
    <subfield code="a">ART KVMJ V12 No1 10</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Abd El Aziz, M. I.</subfield>
  </datafield>
  <datafield tag="240" ind1="1" ind2="0">
    <subfield code="a">kafrelsheikh veterinary medical journal, 2014 v. 12 (1)</subfield>
    <subfield code="h">[electronic resource].</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="4">
    <subfield code="a">The effect of tilmicosin and apramycin alone or together in treatment of experimentally infected chickens with Mycoplasma Gallisepticum only or with Escherichia coli</subfield>
    <subfield code="h">[electronic resource].</subfield>
  </datafield>
  <datafield tag="246" ind1="1" ind2="5">
    <subfield code="a">&#x62A;&#x623;&#x62B;&#x64A;&#x631; &#x643;&#x644; &#x645;&#x646; &#x627;&#x644;&#x62A;&#x644;&#x645;&#x64A;&#x643;&#x648;&#x632;&#x64A;&#x646; &#x648;&#x627;&#x644;&#x623;&#x628;&#x631;&#x627;&#x645;&#x64A;&#x633;&#x646; &#x645;&#x646;&#x641;&#x631;&#x62F;&#x64A;&#x646; &#x623;&#x648; &#x645;&#x62C;&#x62A;&#x645;&#x639;&#x64A;&#x646; &#x641;&#x64A; &#x639;&#x644;&#x627;&#x62C; &#x627;&#x644;&#x62F;&#x62C;&#x627;&#x62C; &#x627;&#x644;&#x645;&#x639;&#x62F;&#x64A; &#x645;&#x639;&#x645;&#x644;&#x64A;&#x627;&#x64B; &#x627;&#x644;&#x645;&#x64A;&#x643;&#x648;&#x628;&#x644;&#x627;&#x632;&#x645;&#x627; &#x62C;&#x627;&#x644;&#x64A;&#x633;&#x628;&#x62A;&#x643;&#x645; &#x645;&#x646;&#x641;&#x631;&#x62F;&#x629; &#x623;&#x648; &#x645;&#x639; &#x627;&#x644;&#x627;&#x64A;&#x634;&#x631;&#x64A;&#x634;&#x64A;&#x627; &#x643;&#x648;&#x644;&#x627;&#x64A;.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">p.139-178</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Includes references.</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Mycoplasmosis remains one of the most expensive and common diseases facing poultry industry. The presence of Mycoplasma gallisepticum (MG) predisposes birds to other infections as Escherichia coli which together causes mortality, and sub-optimal performance. Therefore, this study was carried out to evaluate the efficacy of tilmicosin, apramycin and both drugs together on experimentally infected chicken with local field isolates of MG only or with E. coli as CRD and CCRD treatments. The present investigation clarified that infected groups treated with both tilmicosin and apramycin showed additive or synergistic interaction between them, which in turn confirmed the safoty use of this combination therapy. The use of the recommended therapeutic dose oftilmicosin (lml/L) or apramycin (0.5gm/L) alone or in combination for 5 successive days after appearance of the clinical signs are of considerable value in the treatment of MG injection in broiler chickens as antimycoplasmal drugs through displayed valuable improvement in clinical symptoms, survival rate, lesion scoring and termination of infection by the mycoplasmacidal effect of both drugs.</subfield>
  </datafield>
  <datafield tag="546" ind1=" " ind2=" ">
    <subfield code="a">Summary in Arabic.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Chickens</subfield>
    <subfield code="x">Diseases.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Mycoplasmatales</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Escherichia coli</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Antibacterial agents</subfield>
    <subfield code="x">therapeutic use</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="3">
    <subfield code="a">apramycin</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">El Shazly, K. A.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">El Kahky, Mona A.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">El Sherbeneyn, Ema M. E.</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
    <subfield code="t">Kafrelsheikh Veterinary Medical Journal. </subfield>
    <subfield code="g">2014.v.12(1)</subfield>
    <subfield code="x">1687-1456</subfield>
    <subfield code="7">nnas</subfield>
    <subfield code="w">u190773</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
    <subfield code="u">http://nile.enal.sci.eg/EALE/2014/KVMJ/1214/1/139.pdf</subfield>
    <subfield code="z">Full Text Article</subfield>
  </datafield>
  <datafield tag="596" ind1=" " ind2=" ">
    <subfield code="a">1</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">AR</subfield>
    <subfield code="2">lcc</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">60062</subfield>
    <subfield code="d">60062</subfield>
  </datafield>
</record>
